Brief: Rosetta Genomics suspends 2017 revenue and unit guidance for Reveal
10/10/2017 14:29
Oct 10 (Reuters) - Rosetta Genomics Ltd ROSG.O :
* Says suspends its previously announced 2017 revenue and
unit guidance for Reveal - SEC filing
* Says intends to update its Reveal revenue and unit
guidance by year-end 2017
Source text : (http://bit.ly/2xvbWDp)
Further company coverage: ROSG.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Rosetta Genomics
See all newsBrief: Interpace Diagnostics Acquires Select Assets Of Rosetta Genomics Out Of Bankruptcy
Brief: Stockholders Approve Genoptix Acquisition Of Rosetta Genomics
Brief: Rosetta Genomics Announces Shareholder Approval Of Merger With Genoptix
Brief: Sabby Management Buys 105,361 ADR Shares Of Rosetta Genomics
Brief: Genoptix Announces Termination Of Merger Agreement With Rosetta Genomics